26 results on '"Cocks, K."'
Search Results
2. PCR119 The Impacts of Age and Gender on Mapped EQ-5D-5L Utilities and Quality-Adjusted Life Years (QALYS) in Cancer Clinical Trials
3. PCN295 Health State Utility Values By Time to Death in Recurrent or Metastatic Squamous-Cell Carcinoma of the Head and Neck
4. PCN317 ASSOCIATIONS BETWEEN THE EQ-5D-3L AND QLU-C10D DESCRIPTIVE SYSTEMS: USE OF CORRELATION NETWORKS TO EXPLORE PREFERENCE DIFFERENCES IN SOLID TUMOR TRIALS
5. PNS366 UNDERSTANDING THE ROLE OF ANCHOR CORRELATIONS IN THE CALCULATION OF MEANINGFUL CHANGE THRESHOLDS FOR HEALTH-RELATED QUALITY OF LIFE RESEARCH
6. SP1 COMPARISON OF GENERIC AND CONDITION-SPECIFIC PREFERENCE MEASURES TO DERIVE HEALTH UTILITIES: A RETROSPECTIVE ANALYSIS OF NIVOLUMAB TRIALS IN SOLID TUMOURS
7. PCN457 THE SISAQOL INITIATIVE: ESTABLISHING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA IN ONCOLOGY RANDOMIZED CLINICAL TRIALS
8. PCN49 INDIRECT COMPARISON OF HRQOL DATA FOR PATIENTS WITH TREATMENT-REFRACTORY METASTATIC COLORECTAL CANCER TREATED WITH TRIFLURIDINE & TIPIRACIL (PRECONNECT TRIAL) COMPARED WITH BSC & REGORAFENIB (CORRECT TRIAL)
9. PCN284 PSYCHOMETRIC EVALUATION AND SCORE INTERPRETATION OF THE NCCN-FACT OVARIAN SYMPTOM INDEX-18 IN PATIENTS WITH ADVANCED OVARIAN CANCER: REAL-WORLD EVIDENCE
10. PCN378 - MINIMALLY IMPORTANT DIFFERENCES FOR INTERPRETING EORTC QLQ-C30 SCORES IN MELANOMA, BREAST CANCER AND HEAD AND NECK CANCER PATIENTS ON BEHALF OF THE EORTC BREAST, HEAD AND NECK, MELANOMA AND QUALITY OF LIFE GROUPS
11. A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) (Checkmate 141)
12. Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments
13. Association of Health-Related Quality of Life (HRQOL) and Healthcare Resource Utilization (HCRU) in Checkmate 141, A Phase 3 Study of Nivolumab Versus Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of The Head and Neck (SCCHN)
14. Health-Related Quality of Life in Oncology – Are we Getting Better?
15. Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan: A Preliminary Model
16. Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?
17. PRM263 - Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments
18. PCN209 - A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) (Checkmate 141)
19. PCN196 - Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan: A Preliminary Model
20. PCN193 - Association of Health-Related Quality of Life (HRQOL) and Healthcare Resource Utilization (HCRU) in Checkmate 141, A Phase 3 Study of Nivolumab Versus Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of The Head and Neck (SCCHN)
21. A Reliability Generalisation of the Eortc Qlq-Br23
22. Responsiveness of the EQ-5D in Oncology: A Meta-Analysis
23. PRM159 - A Reliability Generalisation of the Eortc Qlq-Br23
24. CA1 - Responsiveness of the EQ-5D in Oncology: A Meta-Analysis
25. PCN245 - Health-Related Quality of Life in Oncology – Are we Getting Better?
26. PCN243 - Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.